Next-generation sequencing in two cases of de novo acute basophilic leukaemia.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
07 2021
Historique:
revised: 17 04 2021
received: 02 03 2021
pubmed: 17 6 2021
medline: 3 2 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

Acute basophilic leukaemia (ABL) is a rare subtype of acute myeloid leukaemia (AML); therefore, few data are available about its biology. Herein, we analysed two ABL patients using flow cytometry and next-generation sequencing (NGS). Two cell populations were detected by flow cytometry in both patients. In Case no. 1, blasts (CD34

Identifiants

pubmed: 34132463
doi: 10.1111/jcmm.16591
pmc: PMC8278069
doi:

Substances chimiques

Antigens, CD34 0
DNA-Binding Proteins 0
Interleukin-3 Receptor alpha Subunit 0
NPM1 protein, human 0
Tumor Suppressor Protein p53 0
Nucleophosmin 117896-08-9
Dioxygenases EC 1.13.11.-
TET2 protein, human EC 1.13.11.-
Proto-Oncogene Proteins c-kit EC 2.7.10.1

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7095-7099

Informations de copyright

© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Références

FEBS J. 2018 Mar;285(5):828-831
pubmed: 29527821
Leuk Res. 2017 May;56:7-12
pubmed: 28152414
Eur J Haematol. 2001 Aug;67(2):72-6
pubmed: 11722593
Blood. 2005 May 15;105(10):3855-61
pubmed: 15687240
J Pathol. 2017 Jul;242(3):347-357
pubmed: 28418072
Leukemia. 2017 Apr;31(4):788-797
pubmed: 28090091
Br J Haematol. 2003 Mar;120(5):774-81
pubmed: 12614208
J Cell Mol Med. 2021 Jul;25(14):7095-7099
pubmed: 34132463
J Clin Oncol. 2011 Jul 20;29(21):e623-6
pubmed: 21576634
Blood. 2011 May 26;117(21):5719-22
pubmed: 21474671
Blood. 2017 Apr 27;129(17):2347-2358
pubmed: 28223278
Cancer Genet Cytogenet. 2006 Jun;167(2):177-81
pubmed: 16737921
JCI Insight. 2018 Feb 22;3(4):
pubmed: 29467326

Auteurs

Takuya Shimizu (T)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Tadakazu Kondo (T)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Mizuki Watanabe (M)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Toshio Kitawaki (T)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takero Shindo (T)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Masakatsu Hishizawa (M)

Department of Hematology, Kyoto-Katsura Hospital, Kyoto, Japan.

Kouhei Yamashita (K)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Akifumi Takaori-Kondo (A)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH